1AI — Algorae Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00- AU$18.23m
- AU$14.29m
- AU$0.08m
Annual balance sheet for Algorae Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4.24 | 4.11 | 3.11 | 2.32 | 3.94 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.03 | 0.096 | 0.043 | 0.041 | 0.083 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4.27 | 4.21 | 3.19 | 2.4 | 4.44 |
| Net Property, Plant And Equipment | 0.005 | 0.005 | 0 | 0 | 0 |
| Total Assets | 4.27 | 4.21 | 3.19 | 2.4 | 4.44 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.239 | 0.45 | 0.178 | 0.17 | 0.177 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.239 | 0.45 | 0.178 | 0.17 | 0.177 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 4.03 | 3.76 | 3.01 | 2.23 | 4.26 |
| Total Liabilities & Shareholders' Equity | 4.27 | 4.21 | 3.19 | 2.4 | 4.44 |
| Total Common Shares Outstanding |